OTC Pharmaceuticals in Australia

Date: September 27, 2016
Pages: 39
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ODDE5345ABAEN
Leaflet:

Download PDF Leaflet

OTC Pharmaceuticals in Australia
SUMMARY

OTC Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Australia
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Australia
  • Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Australia otc pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Australia otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Australia otc pharmaceuticals market by value in 2015?
  • What will be the size of the Australia otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Australia otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Australia's otc pharmaceuticals market?
KEY HIGHLIGHTS

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.

The Australian OTC pharmaceuticals market generated total revenues of $3,780.1m in 2015, representing a compound annual growth rate (CAGR) of 3.9% between 2011 and 2015.

Traditional medicines registered the highest sales value in the Australian OTC pharmaceuticals market in 2015, with total sales of $1,059.9m, equivalent to 28.0% of the market's overall value.

According to OECD statistics, Australia spends around 9.3% of its GDP on healthcare. Australians today enjoy one of the longest life expectancies in the world according to 2015 figures.
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
GlaxoSmithKline Plc
Pfizer Inc.
Reckitt Benckiser Group plc
Suntory Group
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Australia OTC pharmaceuticals market value: $ million, 2011-15
Table 2: Australia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: Australia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: Australia OTC pharmaceuticals market share: % share, by value, 2015
Table 5: Australia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: Australia OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 7: GlaxoSmithKline Plc: key facts
Table 8: GlaxoSmithKline Plc: key financials ($)
Table 9: GlaxoSmithKline Plc: key financials (£)
Table 10: GlaxoSmithKline Plc: key financial ratios
Table 11: Pfizer Inc.: key facts
Table 12: Pfizer Inc.: key financials ($)
Table 13: Pfizer Inc.: key financial ratios
Table 14: Reckitt Benckiser Group plc: key facts
Table 15: Reckitt Benckiser Group plc: key financials ($)
Table 16: Reckitt Benckiser Group plc: key financials (£)
Table 17: Reckitt Benckiser Group plc: key financial ratios
Table 18: Suntory Group: key facts
Table 19: Suntory Group: key financials ($)
Table 20: Suntory Group: key financials (¥)
Table 21: Suntory Group: key financial ratios
Table 22: Australia size of population (million), 2011-15
Table 23: Australia gdp (constant 2005 prices, $ billion), 2011-15
Table 24: Australia gdp (current prices, $ billion), 2011-15
Table 25: Australia inflation, 2011-15
Table 26: Australia consumer price index (absolute), 2011-15
Table 27: Australia exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Australia OTC pharmaceuticals market value: $ million, 2011-15
Figure 2: Australia OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: Australia OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: Australia OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: Australia OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: Australia OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Australia, 2015
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2015
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2015
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2015
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2015
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2015
Figure 13: GlaxoSmithKline Plc: revenues and profitability
Figure 14: GlaxoSmithKline Plc: assets and liabilities
Figure 15: Pfizer Inc.: revenues and profitability
Figure 16: Pfizer Inc.: assets and liabilities
Figure 17: Reckitt Benckiser Group plc: revenues and profitability
Figure 18: Reckitt Benckiser Group plc: assets and liabilities
Figure 19: Suntory Group: revenues and profitability
Figure 20: Suntory Group: assets and liabilities

COMPANIES MENTIONED

GlaxoSmithKline Plc
Pfizer Inc.
Reckitt Benckiser Group plc
Suntory Group
Skip to top


OTC Pharmaceuticals in Singapore US$ 350.00 Sep, 2016 · 40 pages
OTC Pharmaceuticals in Asia-Pacific US$ 350.00 Sep, 2016 · 36 pages
OTC Pharmaceuticals in China US$ 350.00 Sep, 2016 · 34 pages
OTC Pharmaceuticals in Japan US$ 350.00 Sep, 2016 · 35 pages
OTC Pharmaceuticals in India US$ 350.00 Sep, 2016 · 39 pages

Ask Your Question

OTC Pharmaceuticals in Australia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: